Phosphonate emerging zinc binding group in matrix metalloproteinase inhibitors

Phosphonate emerging zinc binding group in matrix metalloproteinase inhibitors
This research contains a comprehensive review of known phosphonate-based MMP inhibitors. Credit: Dr. Paolo Tortorella, Bentham Science Publishers

Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases, responsible for the degradation of the extracellular matrix (ECM). Their involvement has been demonstrated in several diseases, among which chronic inflammation and cancer; therefore, they have been considered interesting therapeutic targets. The design of MMP inhibitors (MMPIs) has largely focused on development of various compounds containing a zinc binding group (ZBG) in their structure, with the hydroxamate being the most potent one.

Currently, there are no MMPI containing hydroxamate function as ZBG in the market, mainly due to their proven toxicity. An alternative function chelating the ion would ensure a better selectivity. This latter aspect is mandatory to obtain clinically exploitable compounds. In this review the phosphonate and bis-phosphonate groups as the ZBG are considered in the development of selective and potent MMPIs.

The authors have been working since a long time on MMP inhibitors containing alternative zinc-binding to hydroxamate, focusing in particular on phosphonic acids, thus contributing to this still interesting research field.

Phosphonate-based are classified on peptide phosphonate; sulphonamide and sulfonyl phosphonate, the most potent; carbamoyl phosphonate, and bisphosphonate that have been identified more recently with an interesting activity on bone resorption.

Moreover, the binding with the MMP active site is discussed in the research paper, 'Phosphonate Emerging Zinc Binding Group in Matrix Metalloproteinase Inhibitors', published in Current Drug Targets.


Explore further

Bacteria's secret weapon against pesticides and antibiotics revealed

More information: Cristina Campestre et al. Phosphonate Emerging Zinc Binding Group in Matrix Metalloproteinase Inhibitors, Current Drug Targets (2015). DOI: 10.2174/1389450116666150113121733
Provided by Bentham Science Publishers
Citation: Phosphonate emerging zinc binding group in matrix metalloproteinase inhibitors (2016, March 15) retrieved 19 January 2020 from https://phys.org/news/2016-03-phosphonate-emerging-zinc-group-matrix.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
5 shares

Feedback to editors

User comments